Icon

AMLODIPINE BESYLATE (nda022026)- (EQ 2.5MG BASE,EQ 5MG BASE,EQ 10MG BASE)

AMLODIPINE BESYLATE SYNTHON PHARMS
EQ 2.5MG BASE,EQ 5MG BASE,EQ 10MG BASE
No Yes
2022-Nov-20 Expired
None None
None No
Amlodipine Orally Disintegrating Tablets™ is indicated for the treatment of hypertension. Amlodipine Orally Disintegrating Tablets™ is indicated for the symptomatic treatment of chronic stable angina. Amlodipine Orally Disintegrating Tablets™ may be used alone or in combination with other antianginal agents. Amlodipine Orally Disintegrating Tablets™ is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine Orally Disintegrating Tablets™ may be used as monotherapy or in combination with other antianginal drugs.
0 0 0
Total Other Developers 28
Drugs with Suitability No
EQ 2.5MG BASE ** ** - - -
EQ 5MG BASE ** ** - - -
EQ 10MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.